BATSK advances 0.3% stock this week in the U.S.

NewsGuard 100/100 Score

BATS Global Markets, a global stock market operator, reports the BATS 1000 Index (BATSK) advanced 0.3% for the week ending March 4 in the U.S. The S&P 500 Index was up 0.1% for the same period.

The BATS 1000 Index was at 14,969.10 as of 4 p.m. ET Friday compared with a final value of 14,925.47 last Friday.

Two of the 10 sectors that comprise the BATS 1000 Index declined on the week: Financials (–1.6%) and Technology and Communications (–0.2%). All other sectors advanced with Healthcare and Pharmaceuticals (+2.3%) and Utilities (+0.8%) leading the way.

Below is an overview of the BATS 1000 Index and sub-indices for the week:

The BATS 1000 Index offers a listings-neutral, broad snapshot of the U.S. equities marketplace by tracking the performance of 1,000 securities classified in 10 important industry sectors. The BATS 1000 Index was launched on July 1, 2009, with a base value of 10,000. The 10 index sectors are adjusted to an equal weighting based on the current value of the index every June during an annual reconstitution process.

The BATS 1000 Index data is available via the Consolidated Tape System (CTS), the operating authority for exchange-listed securities information, enabling distribution of the data to the public via the Internet and other electronic media.

SOURCE BATS Global Markets

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.